Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04356443 · ClinicalTrials.gov registry record
Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 25
- Enrollment target
NCT04356443: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT04356443 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04356443 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study uses the AirGo band to monitor changes in tidal ventilation in spontaneously breathing patients with COVID-19 associated respiratory failure. It aims to recognize patterns of ventilation associated with worsening respiratory failure in this patient population. If successful, this study will lead to the development of new robust methods for real-time, continuous monitoring of respiratory function in patients with respiratory failure. In turn, such monitoring methods may enable improvements in the medical management of respiratory failure and timing of interventions.
Primary Outcome
Progression of respiratory failure to require endotracheal intubation (and mechanical ventilation)
Interventions
- DEVICE AirGo Respiratory Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-04-15 |
| Est. Completion | 2020-12-31 |
Why NCT04356443 stopped before completion
NCT04356443 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which AirGo Respiratory Monitor is the first listed.
NCT04356443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04356443 about?
NCT04356443 is a clinical study titled "Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection". This study uses the AirGo band to monitor changes in tidal ventilation in spontaneously breathing patients with COVID-19 associated respiratory failure. It aims to recognize patterns of ventilation associated with worsening respiratory failure in this patient population. If successful, this study wi...
What is the current status of trial NCT04356443?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2020-04-15. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04356443?
The interventions under investigation include: AirGo Respiratory Monitor (DEVICE).
Who is sponsoring clinical trial NCT04356443?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI